<?xml version='1.0' encoding='utf-8'?>
<container xmlns="https://open.law/schemas/library" xmlns:cache="https://open.law/schemas/cache" xmlns:citations="https://open.law/schemas/citations" xmlns:macro="https://open.law/schemas/macro" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xsl="http://www.w3.org/1999/XSL/Transform" xmlns:codified="https://open.law/schemas/codified" xmlns:codify="https://open.law/schemas/codify" xmlns:xi="http://www.w3.org/2001/XInclude">
  <prefix>Chapter</prefix>
  <num>08</num>
  <heading>Maryland HIV Prevention Case Management Program</heading>
  <section>
    <prefix>Regulation</prefix>
    <num>.01</num>
    <heading>Scope and Purpose.</heading>
    <text>This chapter:</text>
    <para>
      <num>A.</num>
      <text>Defines the Maryland AIDS Drug Assistance Program Fund;</text>
    </para>
    <para>
      <num>B.</num>
      <text>Sets forth the responsibilities of the Maryland Department of Health with respect to the Maryland AIDS Drug Assistance Program Fund; and</text>
    </para>
    <para>
      <num>C.</num>
      <text>Establishes eligibility criteria for receipt of HIV prevention and care services from the Fund.</text>
    </para>
    <annotations/>
  </section>
  <section>
    <prefix>Regulation</prefix>
    <num>.02</num>
    <heading>Definitions.</heading>
    <para>
      <num>A.</num>
      <text>In this chapter, the following terms have the meanings indicated.</text>
    </para>
    <para>
      <num>B.</num>
      <text>Terms Defined.</text>
      <para>
        <num>(1)</num>
        <text>“Acquired immunodeficiency syndrome (AIDS)” means the medical condition caused by the human immunodeficiency virus.</text>
      </para>
      <para>
        <num>(2)</num>
        <text>“Department” means the Maryland Department of Health.</text>
      </para>
      <para>
        <num>(3)</num>
        <text>"Fund" means the Maryland AIDS Assistance Program Fund.</text>
      </para>
      <para>
        <num>(4)</num>
        <text>“Human immunodeficiency virus (HIV)” means the virus that causes AIDS.</text>
      </para>
      <para>
        <num>(5)</num>
        <text>“Ryan White HIV/AIDS Program (RWHAP)” means the federal HIV/AIDS initiative administered by the U.S. Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA), HIV/AIDS Bureau (HAB).</text>
      </para>
    </para>
    <annotations/>
  </section>
  <section>
    <prefix>Regulation</prefix>
    <num>.03</num>
    <heading>Maryland AIDS Drug Assistance Program Fund.</heading>
    <para>
      <num>A.</num>
      <text>The Maryland AIDS Drug Assistance Program Fund is a nonlapsing, special fund created by Health-General Article, §24-1801, Annotated Code of Maryland, for HIV treatment and care, which is generated from:</text>
      <para>
        <num>(1)</num>
        <text>The 340B Drug Pricing Program and any supplemental rebate dollars; and</text>
      </para>
      <para>
        <num>(2)</num>
        <text>Interest earned on the balance of the Fund.</text>
      </para>
    </para>
    <para>
      <num>B.</num>
      <text>The Department may only expend funds in accordance with Title 26 of the Public Health Service Act governing the allowable uses of RWHAP funds or to meet State-identified HIV priorities.</text>
    </para>
    <para>
      <num>C.</num>
      <text>The Department may make grant awards under the Fund.</text>
    </para>
    <para>
      <num>D.</num>
      <text>Any unspent portions of the Fund shall remain in the Fund and may not revert to the General Fund of the State.</text>
    </para>
    <para>
      <num>E.</num>
      <text>Money expended from the Fund is additive to, and is not intended to take the place of, funding that would otherwise be appropriated to the Department for HIV:</text>
      <para>
        <num>(1)</num>
        <text>Surveillance;</text>
      </para>
      <para>
        <num>(2)</num>
        <text>Prevention;</text>
      </para>
      <para>
        <num>(3)</num>
        <text>Treatment; or</text>
      </para>
      <para>
        <num>(4)</num>
        <text>Care.</text>
      </para>
    </para>
    <annotations/>
  </section>
  <section>
    <prefix>Regulation</prefix>
    <num>.04</num>
    <heading>Responsibilities of the Department.</heading>
    <text>The Department:</text>
    <para>
      <num>A.</num>
      <text>Shall administer the Fund; and</text>
    </para>
    <para>
      <num>B.</num>
      <text>May spend the Fund on statutorily permitted purposes under the RWHAP or State-identified HIV priorities.</text>
    </para>
    <annotations/>
  </section>
  <section>
    <prefix>Regulation</prefix>
    <num>.05</num>
    <heading>Eligibility Criteria.</heading>
    <para>
      <num>A.</num>
      <text>The Fund shall be the reasonable payor of last resort for receipt of HIV prevention and care services; and</text>
    </para>
    <para>
      <num>B.</num>
      <text>Eligible individuals shall have exhausted all other potential payors, including but not limited to:</text>
      <para>
        <num>(1)</num>
        <text>Third-party insurance;</text>
      </para>
      <para>
        <num>(2)</num>
        <text>Medicaid; and</text>
      </para>
      <para>
        <num>(3)</num>
        <text>Medicare.</text>
      </para>
    </para>
    <annotations/>
  </section>
  <annotations>
    <annotation type="Authority" dest="container">: Health-General Article, §24-1801, Annotated Code of Maryland</annotation>
    <annotation type="History" subtype="Administrative History" dest="container" effective="2019-05-20">Effective date: May 20, 2019 (46:10 Md. R. 490)</annotation>
    <annotation type="History" subtype="Administrative History" dest="container" effective="2023-12-25" discontinuity="true">Regulations <cite path="|10|52|08|.01">.01</cite>—<cite path="|10|52|08|.16">.16</cite> under Maryland HIV Prevention Case Management Program repealed and new Regulations <cite path="|10|52|08|.01">.01</cite>—<cite path="|10|52|08|.05">.05</cite> under Maryland AIDS Drug Assistance Program Fund adopted effective December 25, 2023 (50:25 Md. R. 1088)</annotation>
  </annotations>
</container>
